ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0270699 | null | Ischemic cerebral necrosis and hemorrhage|Neonatal maladjustment syndrome|NMS|Convulsive foals|Ischaemic cerebral necrosis and haemorrhage|neonatal maladjustment syndrome (NMS) of newborn horse|Dummies|Barkers|Wanderers | Neonatal maladjustment syndrome |
C0030424 | Infection with TREMATODA of the genus PARAGONIMUS. | DISTOMIASIS, PULMONARY|Infections, Paragonimus westermani|Paragonimus westermani Infection|Paragonimus westermani Infections|Infection, Paragonimus westermani|Infection caused by Paragonimus|Paragonimiasis|Paragonimus Infection|Infections, Paragonimus|paragonimiasis|Infection, Paragonimus|PARAGONIMIASIS|lung fluke infection|Lung fluke infection|Pulmonary distomiasis|Infection by Paragonimus|Lung fluke disease|Paragonimosis|Infection by Paragonimus, NOS|Pulmonary distomatosis|Pulmonary paragonimiasis|Paragonimus Infections|Infection caused by Paragonimus (disorder)|HEMOPTYSIS, ENDEMIC|Paragonimiases | Paragonimiasis |
C0030425 | A genus of lung flukes of the family Troglotrematidae infecting humans and animals. This genus consists of several species one of which is PARAGONIMUS WESTERMANI, a common lung fluke in humans. | paragonimus|Paragonimus|Paragonimus species|Genus: Paragonimus|Paragonimus, NOS|Paragonimus (organism) | Paragonimus |
C0008864 | A non-essential amino acid. In hepatocytes, L-citrulline is synthesized in the urea cycle by the addition of carbon dioxide and ammonia to ornithine. L-citrulline is converted into L-arginine by the enzymes argininosuccinate synthetase and argininosuccinate lyase in the presence of L-aspartate and ATP. Subsequently, L-arginine is converted to nitric oxide by nitric oxide synthase and L-citrulline is regenerated as a by-product. | 2-Amino-5-(carbamoylamino)pentanoic Acid|l-citrulline|N5-(Aminocarbonyl)-L-ornithine|L-Ornithine, N5-(aminocarbonyl)-|L-2-Amino-5-ureidovaleric acid|N5-(Aminocarbonyl)ornithine|N5-carbamoylornithine|citrulline|(S)-2-Amino-5-ureidopentanoic acid|2-Amino-5-ureidovaleric acid|Citrulina|delta-Ureidonorvaline|Product containing citrulline (medicinal product)|Citrulline (substance)|alpha-amino-delta-Ureidovaleric acid|N(5)-(Aminocarbonyl)-L-ornithine|N(delta)-Carbamylornithine|N5-Carbamoyl-L-ornithine|CITRULLINE|Cit|α-amino-δ-ureidovaleric acid|Citrulline-containing product|δ-ureidonorvaline|L-citrulline|Citrulline|L-Citrulline|2-amino-5-(carbamoylamino)pentanoic acid | citrulline |
C0059541 | A colorless, highly flammable, liquid cyclic ether. Diepoxybutane is primarily used for research purposes, but is also used as a curing agent for polymer resins and as a cross-linking agent for making synthetic textile fibers. Exposure to this substance can severely irritate and burn the eyes and skin and can cause liver damage. Diepoxybutane is reasonably anticipated to be a human carcinogen based on evidence of carcinogenicity in experimental animals. (NCI05) | diepoxybutane|Diepoxybutane|meso-diepoxybutane|Butadiene Dioxide|2,2'-bioxirane|1,1'-Bi(ethylene Oxide)|butadiene bisoxide|2,2'-Bioxirane|DEB|1,2,3,4- Diepoxybutane|erythritol anhydride|diepoxybutane, meso-|butadiene dioxide|butadiene diepoxide | erythritol anhydride |
C0032071 | Community of tiny aquatic PLANTS and ANIMALS, and photosynthetic BACTERIA, that are either free-floating or suspended in the water, with little or no power of locomotion. They are divided into PHYTOPLANKTON and ZOOPLANKTON. | plankton|Plankton | Plankton |
C0062503 | Ubiquitous macromolecules associated with the cell surface and extracellular matrix of a wide range of cells of vertebrate and invertebrate tissues. They are essential cofactors in cell-matrix adhesion processes, in cell-cell recognition systems, and in receptor-growth factor interactions. (From Cancer Metastasis Rev 1996; 15(2): 177-86; Hepatology 1996; 24(3): 524-32) | Sulfate Proteoglycans, Heparan|Heparan Sulfate Proteoglycans|HSPG|Proteoglycans, Heparan Sulfate|Proteoheparan Sulfate|Heparan Sulfate Proteoglycan|Heparan sulfate proteoglycan|Proteoglycan, Heparan Sulfate | Heparan Sulfate Proteoglycans |
C0004933 | The application of modern theories of learning and conditioning in the treatment of behavior disorders. | Behaviour modification|Behavioral psychotherapy|Modification, Behavior|Behavior modification psychotherapy|Behavioural psychotherapy|Behavioral therapy|Behavioral Intervention|behavioral intervention|Modifications, Behavior|Behavior modification treatments and procedures|Behavioral therapy (regime/therapy)|Behaviour modification technique|Behavior Therapies|behavioral psychotherapy|behavioural therapy|behavior therapy|Behavior Therapy|Therapy, Behavior|Behaviour modification treatments and procedures|Behaviour therapy|Behavioral Modification|behavior modification techniques|behavioral interventions|Behavioral Treatment|Behavior or Life Style Modifications|Behaviour conditioning therapy|Behavior therapy|Therapy, Conditioning|behavioral therapy|BEHAVIORAL THERAPY|Behavior Modifications|Behavioural therapy|Behavioral Treatments|Therapies, Conditioning|Behaviour modification psychotherapy|behavior modification|Conditioning Therapy|Behavior modification technique|Behavior Conditioning Therapy|behavior modification technique|behaviour therapy|Behavior modification|Conditioning Therapies|Behavior Modification|Behavior conditioning therapy|Behavioral Interventions|Therapies, Behavior|Behavioral Therapy | Behavior Therapy |
C0009244 | A type of psychotherapy utilized to treat different forms of mental disorders.The treatment involves the identification of unhelpful or destructive patterns of thinking and behaviors and the subsequent replacement with behaviors that are beneficial and constructive. | Cognitive Therapies|Therapies, Cognitive Behavior|Cognitive Behavioral Therapies|Psychotherapies, Cognitive|cognitive and behavioral therapy|Cognition Therapy|Psychotherapy, Cognitive|behavioral cognitive therapy|cognitive therapies|Therapy, Cognition|Cognitive and behavioural therapy|Cognitive and behavioral therapy (regime/therapy)|cognitive behaviour therapy|behaviour cognitive therapy|cognitive behavior modification|Cognitive-behavior therapy|Therapy, Cognitive Behavior|Therapies, Cognitive|Cognitive Behavior Therapy|Cognitive therapy|cognitive behavior therapy|Cognitive-behaviour therapy|Cognitive Psychotherapy|Cognition Therapies|Cognitive Psychotherapies|cognitive behavioural therapy|Therapies, Cognition|cognitive behavioral therapy|Behavior Therapies, Cognitive|Cognitive Behavior Therapies|CT|CBT - cognitive and behavioural therapy|CBT|cognitive therapy|Cognitive approach|Therapy, Cognitive Behavioral|Cognitive therapy (regime/therapy)|therapy behavior cognitive|CBT - cognitive and behavioral therapy|Cognitive and behavioral therapy|Psychotherapy - cognitive|Behavioral Therapies, Cognitive|Psychotherapy - cognitive (regime/therapy)|Behavior Therapy, Cognitive|Behavioral Therapy, Cognitive|Cognitive therapy approach|Cognitive Therapy|Cognitive Behavioral Therapy|therapy cognitive|cognitive psychotherapy|Therapy, Cognitive|Therapies, Cognitive Behavioral | Cognitive Therapy |
C1179841 | null | Cell membrane protein|Plasma membrane protein | Plasma membrane protein |
C0037853 | Interactive processes between the oocyte (OVUM) and the sperm (SPERMATOZOA) including sperm adhesion, ACROSOME REACTION, sperm penetration of the ZONA PELLUCIDA, and events leading to FERTILIZATION. | Oocyte-Sperm Interactions|Ovum Sperm Interactions|Sperm-Oocyte Interactions|Ovum-Sperm Interaction|Sperm Egg Interactions|Sperm Ovum Interactions|Egg Sperm Interactions|Gamete Interactions|Sperm-Ovum Interaction|Oocyte Sperm Interactions|Sperm-ovum interactions|Sperm Oocyte Interactions|Ovum-Sperm Interactions|Oocyte-Sperm Interaction|Sperm-Egg Interactions|Sperm-Oocyte Interaction|Egg-Sperm Interaction|Egg-Sperm Interactions|Sperm-Egg Interaction|Gamete Interaction | Sperm-Ovum Interactions |
C0086860 | A DNA sequence at which RNA polymerase binds and initiates transcription. | promoters|promotors|Promoter|promotor|promoter | Promoter |
C1334927 | A carcinoma that arises from the anatomic structures of the neck region. | Carcinoma of the Neck|Carcinoma of Neck | Neck Carcinoma |
C0010808 | A type II keratin found associated with KERATIN-18 in simple, or predominately single layered, internal epithelia. | Keratin 8|Endo A Cytokeratin|Cytokeratin, Endo-A|Cytokeratin 8|Keratin-8|Endo-A Cytokeratin|Cytokeratin-8 | Cytokeratin 8 |
C0023531 | A white patch lesion found on a MUCOUS MEMBRANE that cannot be scraped off. Leukoplakia is generally considered a precancerous condition, however its appearance may also result from a variety of HEREDITARY DISEASES. | leukoplakias|Leukoplakia|Leukoplakic Lesion|Lesions, Leukoplakic|Keratotic Plaque|leukoplakia|Leukoplakia, NOS|Lesion, Leukoplakic|Leukoplakias|Leucoplakia|Leukoplakic Lesions|LEUKOPLAKIA|leukokeratosis|Leukoplakia (disorder)|Leukoplakia (morphologic abnormality)|leucoplakia | Leukoplakia |
C0023532 | A white patch seen on the oral mucosa. It is considered a premalignant condition and is often tobacco-induced. When evidence of Epstein-Barr virus is present, the condition is called hairy leukoplakia (LEUKOPLAKIA, HAIRY). | Oral idiopathic keratosis|Leukoplakia of Oral Mucosa|Oral Leukoplakias|Leukokeratosis of oral mucosa|Oral leukoplakia|Leukoplakia of oral mucosa, NOS|Oral Leukokeratosis|Oral leucoplakia|Keratosis, Oral|Leukoplakia of the Mouth|Leukoplakias, Oral|LEUKOPLAKIA ORAL|oral leukoplakia|Leukoplakia, Oral|LEUKOPLAKIA OF MOUTH|Leucoplakia of oral mucosa|leukoplakia, oral|Leukoplakia of the Oral Mucosa|Leukoplakia of oral mucosa|Oral leukoplasia|Oral Keratoses|Mouth Leukoplakia|Oral Leukoplakia|Leukoplakia of Mouth|oral keratosis|Leukokeratosis of Oral Mucosa|Oral idiopathic leukoplakia|Keratoses, Oral|Oral Cavity Leukoplakia|Oral Keratosis|Oral Leukokeratoses|Leukoplakia of oral mucosa (disorder)|Leukokeratosis, Oral|leukoplakia mouth|Oral white patch|Oral white plaque|Leukokeratoses, Oral|leukoplakia oral|Oral idiopathic white patch|Oral leukokeratosis | Leukoplakia, Oral |
C0060794 | null | sulfated fucans|fucan sulfate|fucoidin|fucoidan | fucoidan |
C0212576 | null | Macrophage Scavenger Receptors|Macrophage Scavenger Receptor|Receptor, Macrophage Scavenger|Scavenger Receptors, Macrophage | Scavenger Receptors, Macrophage |
C0050486 | null | acetyl-low density lipoproteins|Acetylated low density lipoprotein|acetylated low density lipoprotein|Low density lipoprotein, acetylated|AcLDL|Acetylated low density lipoprotein (substance)|acetylated LDL | acetyl-LDL |
C0034782 | null | Signal Transduction, Receptor-Mediated|Signal Transductions, Receptor-Mediated|Receptor-Mediated Signal Transductions|Receptor Mediated Signal Transduction | Receptor-Mediated Signal Transduction |
C1011520 | A plant species of the genus PANAX. It contains damarane-type tetracyclic TRITERPENES. The common names of Sanchi or Tienchi are also used for Panax pseudoginseng which is distinguished in containing oleanane-type pentacyclic triterpenoids. | Panax pseudoginseng var. notoginseng|san-qi|sanchi ginseng|notoginsengs, Panax|tienchi|Panax notoginseng|panax notoginseng|Panax notoginsengs | Panax notoginseng |
C0035542 | Enzymes that catalyze the hydrolysis of ester bonds within RNA. EC 3.1.-. | Ribonuclease|Ribonucleases|ribonuclease|ribonucleases|RNA Nucleases|Ribonuclease (RNA'ase)|Nucleases, RNA|rnase|Ribonuclease Family Protein|Ribonuclease (substance)|RNase | Ribonucleases |
C0032417 | A group of uridine ribonucleotides in which the phosphate residues of each uridine ribonucleotide act as bridges in forming diester linkages between the ribose moieties. | Acids, Polyuridylic|Polynucleotides, Uracil|Poly(rU)|5'-Uridylic acid, homopolymer|Polyuridylic Acids|Uracil Polynucleotides | Poly U |
C0582119 | A class of enzymes that catalyze the movement of ions or molecules across or within membranes. | translocase|Translocase|Translocase (substance) | Translocase |
C0068813 | null | Nitrile hydratase|nitrile hydratase|Nitrilase|Nitrile hydratase (substance) | nitrile hydratase |
C0015637 | A colorless liquid extracted from oils of plants such as citronella, neroli, cyclamen, and tuberose. It is an intermediate step in the biological synthesis of cholesterol from mevalonic acid in vertebrates. It has a delicate odor and is used in perfumery. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) | farnesol|3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol|trans-Farnesol|FARNESOL|FARNESOL, (2E,6E)-|Farnesol|Farnesyl Alcohol|Trimethyl dodecatrienol|Farnesol (substance)|3,7,11-trimethyl-2,6,10-dodecatrien-1-ol|Farnesyl alcohol|(E,E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol|2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-|farnesol, (2E,6E)|Farnesol, (2E,6E)- | farnesol |
C0146712 | null | Diponium Bromide|Dipenine Bromide|2,2-Dicyclopentylacetic Acid 2'-diethylaminoethyl Ester Ethobromide|triethyl(2-hydroxyethyl)ammonium bromide dicyclopentyl acetate|DIPONIUM BROMIDE | diponium bromide |
C0146712 | null | Diponium Bromide|Dipenine Bromide|2,2-Dicyclopentylacetic Acid 2'-diethylaminoethyl Ester Ethobromide|triethyl(2-hydroxyethyl)ammonium bromide dicyclopentyl acetate|DIPONIUM BROMIDE | diponium bromide |
C0079160 | A theoretical representative nucleotide or amino acid sequence in which each nucleotide or amino acid is the one which occurs most frequently at that site in the different sequences which occur in nature. The phrase also refers to an actual sequence which approximates the theoretical consensus. A known CONSERVED SEQUENCE set is represented by a consensus sequence. Commonly observed supersecondary protein structures (AMINO ACID MOTIFS) are often formed by conserved sequences. | Sequence, Consensus|Consensus Sequences|Sequences, Consensus|Consensus Sequence | Consensus Sequence |
C0241279 | null | null | SUBCUTANEOUS TUMOR |
C0669368 | A CALCIUM-dependent, constitutively-expressed form of nitric oxide synthase found primarily in NERVE TISSUE. | Nitric Oxide Synthase Type I|NOS1 Protein|Nitric Oxide Synthase, Type I|Neural Constitutive Nitric Oxide Synthase|nNOS Enzyme|NCNOS Enzyme|Neuronal Nitric Oxide Synthase | Nitric Oxide Synthase Type I |
C0054704 | null | Carbon-monoxide oxidase (substance)|carbon monoxide oxidase|CM-MB oxidoreductase|Carbon-monoxide oxidase | carbon monoxide-methylene blue oxidoreductase |
C0036982 | Acute hemorrhage or excessive fluid loss resulting in HYPOVOLEMIA. | Haemorrhagic shock|hemorrhagic shock|Hemorrhagic shock|Hemorrhagic shock (disorder)|Shock, hemorrhagic|Hemorrhagic Shock|haemorrhagic shock | Shock, Hemorrhagic |
C0360714 | Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis. | Statin|Inhibitors, Hydroxymethylglutaryl Coenzyme A|hydroxymethylglutaryl-coenzyme A reductase inhibitor|HMG-COA REDUCTASE INHIBITORS|Hydroxymethylglutaryl-CoA Inhibitors|Inhibitors, Hydroxymethylglutaryl-CoA|Inhibitors, Hydroxymethylglutaryl-CoA Reductase|HMG CoA Reductase Inhibitors|Statin-containing product|Statins|Inhibitors, HMG-CoA Reductase|HMG-CoA reductase inhibitor|Statins, HMG CoA|HMG-CoA Reductase Inhibitor|Hydroxymethylglutaryl-Coenzyme A Inhibitors|Reductase Inhibitors, HMG-CoA|HMG-CoA reductase inhibitors|HMG-CoA Reductase Inhibitors|Substance with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor mechanism of action (substance)|statin|HMG-CoA reductase inhibitor, NOS|Inhibitors, Hydroxymethylglutaryl-Coenzyme A|Reductase Inhibitors, Hydroxymethylglutaryl-CoA|Statins, HMG-CoA|Hydroxymethylglutaryl CoA Reductase Inhibitors|Inhibitors, HMG CoA Reductase|HMG-CoA reductase inhibitor-containing product|Hydroxymethylglutaryl-CoA Reductase Inhibitors|HMG-CoA Statins|Product containing 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (product)|Inhibitors, Hydroxymethylglutaryl CoA|Hydroxymethylglutaryl CoenzymeA Reductase Inhibitors | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
C0019652 | Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each. | histone|Histones|Histone|histones | Histones |
C0286651 | A synthetic lipid-lowering agent. Atorvastatin competitively inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis. Atorvastatin also increases the number of LDL receptors on hepatic cell surfaces to enhance uptake and catabolism of LDL and reduces LDL production and the number of LDL particles. This agent lowers plasma cholesterol and lipoprotein levels and modulates immune responses by suppressing MHC II (major histocompatibility complex II) on interferon gamma-stimulated, antigen-presenting cells such as human vascular endothelial cells. (NCI04) | atorvastatinum|(betaR,deltaR)-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid|(betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-pyrrole-1-heptanoic Acid|Product containing atorvastatin (medicinal product)|(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid|Atorvastatin (substance)|Atorvastatin-containing product|ATORVASTATIN|atorvastatina|atorvastatine|Atorvastatin|atorvastatin | atorvastatin |
C0048044 | An analogue of GAMMA-AMINOBUTYRIC ACID. It is an irreversible inhibitor of 4-AMINOBUTYRATE TRANSAMINASE, the enzyme responsible for the catabolism of GAMMA-AMINOBUTYRIC ACID and is used as an anticonvulsant. (From Martindale The Extra Pharmacopoeia, 31st ed) | 5-hexenoic acid, 4-amino-|4-Amino-5-hexenoic acid|gamma Vinyl GABA|Vigabatrin-containing product|Vinyl gamma-aminobutyric acid|GVG|Vigabatrina|Gamma vinyl GABA|Gamma vinyl gamma aminobutyric acid|gamma-Vinyl GABA|gamma-vinyl gaba|Gamma-Vinyl Gaba|gamma Vinyl gamma Aminobutyric Acid|gamma-Vinyl-gamma-aminobutyric acid|4-Amino-5-Hexenoic Acid|5-Hexenoic Acid, 4-Amino-|Gamma Vinyl Gaba|VIGABATRIN|Vigabatrine|gamma-Vinyl-GABA|gaba gamma vinyl|Vigabatrin|4-Amino-5-hexenoic Acid|Product containing vigabatrin (medicinal product)|gamma-Vinyl-gamma-Aminobutyric Acid|Vinyl Gamma-Aminobutyric Acid|vigabatrin|Vigabatrinum|gamma vinyl gaba|4-amino-5-hexenoic acid|Vigabatrin (substance)|vinyl gamma-aminobutyric acid | vigabatrin |
C0230653 | A membrane raft that forms small pit, depression, or invagination that communicates with the outside of a cell and extends inward, indenting the cytoplasm and the cell membrane. Examples include flask-shaped invaginations of the plasma membrane in adipocytes associated with caveolin proteins, and minute pits or incuppings of the cell membrane formed during pinocytosis. Caveolae may be pinched off to form free vesicles within the cytoplasm. [GOC:mah, ISBN:0721662544, PMID:16645198] | Micropinocytotic vesicle (cell structure)|Caveolas|caveolae|Micropinocytotic vesicle|Micropinocytotic vesicle, NOS|caveola|Caveola|Caveolae | Caveolae |
C0009002 | A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) | Chlorophenoxyisobutyrate, Ethyl|2-(p-Chlorophenoxy)-2-methylpropionic acid ethyl ester|Clofibrate (substance)|Ethyl clofibrate|Ethyl chlorophenoxyisobutyrate|clofibrates|Ethyl 2-(4-Chlorophenoxy)-2-methylpropanoate|CLOFIBRATE|clofibrate|Clofibratum|Propanoic acid, 2-(4-chlorophenoxy)-2-methyl-, ethyl ester|Clofibrate-containing product|alpha-p-Chlorophenoxyisobutyryl ethyl ester|CFB|2-(4-chlorophenoxy)-2-methylpropanoic acid ethyl ester|2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester|Clofibrato|EPIB|Clofibrate|Product containing clofibrate (medicinal product)|Ethyl p-Chlorophenoxyisobyturate|Ethyl 2-(p-chlorophenoxy)isobutyrate|alpha-(p-Chlorophenoxy)isobutyric acid, ethyl ester|Clofibric Acid, Ethyl Ester|ethyl p-chlorophenoxyisobyturate|Ethyl Chlorophenoxyisobutyrate|ethyl 2-(4-chlorophenoxy)-2-methylpropanoate | clofibrate |
C1449704 | null | Fibrates | Fibrates |
C0870537 | null | faces recognition | face recognition |
C0037857 | Male germ cells derived from the haploid secondary SPERMATOCYTES. Without further division, spermatids undergo structural changes and give rise to SPERMATOZOA. | Spermoblast|Spermatoblast|Spermatoblasts|spermatoblast|spermid|Spermatid|Spermatids|nematoblast|Spermatid (cell)|spermoblast|spermatid|Nematoblast | Spermatid |
C1373026 | null | Hormone Receptor Antagonists [MoA] | Hormone Receptor Antagonists |
C0065898 | null | melanosome concentrating hormone|melanin concentrating hormone|melanophore-concentrating hormone|melanin-concentrating hormone | melanin-concentrating hormone |
C1504561 | Reduced ingestion of food. | Oral Intake Reduced|Hypophagia|Decreased Oral Intake|Decreased PO Intake|Poor Oral Intake | Hypophagia |
C0237955 | avoiding social or emotional involvement | psychologic withdrawal|withdrawal (defense mechanism) | Withdrawal (Defense Mechanism) |
C1472358 | null | null | Amblyomma triste |
C0042895 | The active production and accumulation of VITELLINS (egg yolk proteins) in the non-mammalian OOCYTES from circulating precursors, VITELLOGENINS. Vitellogenesis usually begins after the first MEIOSIS and is regulated by estrogenic hormones. | vitellogenesis|Vitellogeneses|Vitellogenesis|yolk formation|yolk production | Vitellogenesis |
C0019360 | An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed) | zona|zonas|ZONA|herpes zoster infection|Zona|Herpes zoster|Herpes zoster infection|herpes zoster|Herpes Zoster|SHINGLES|shingles|Herpes zoster, NOS|Herpes zoster (disorder)|Shingles|HERPES ZOSTER|zoster|Shingles (Disease)|herpes zona|Zoster|Herpes zoster NOS | Herpes zoster disease |
C0019360 | An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed) | zona|zonas|ZONA|herpes zoster infection|Zona|Herpes zoster|Herpes zoster infection|herpes zoster|Herpes Zoster|SHINGLES|shingles|Herpes zoster, NOS|Herpes zoster (disorder)|Shingles|HERPES ZOSTER|zoster|Shingles (Disease)|herpes zona|Zoster|Herpes zoster NOS | Herpes zoster disease |
C1151067 | Catalysis of the incorporation of one atom from molecular oxygen into a compound and the reduction of the other atom of oxygen to water. [http://www.onelook.com/, ISBN:0198506732] | monooxygenase activity | monooxygenase activity |
C0015648 | A species of helminth commonly called the sheep liver fluke. It occurs in the biliary passages, liver, and gallbladder during various stages of development. Snails and aquatic vegetation are the intermediate hosts. Occasionally seen in man, it is most common in sheep and cattle. | Fasciola hepatica|liver flukes|Liver flukes, NOS|fasciola hepatica|Liver fluke, NOS|Fasciola hepaticas|Sheep liver fluke|Liver flukes|Liver Flukes|Fasciola hepatica (organism)|sheep liver fluke|LIVER FLUKE|FASCIOLA HEPATICA|Common liver fluke|Flukes, Liver|liver fluke|Fluke, Liver|fluke liver|hepatica, Fasciola|Liver trematode, NOS|Liver Fluke | Fasciola hepatica |
C0814087 | Memory related to spatial information. | spatial memory|memory spatial|Memories, Spatial|Spatial Memories|Memory, Spatial | Spatial Memory |
C0751318 | null | Mus musculus domesticus|domesticus, Mus musculus | Mus domesticus |
C1444154 | null | Bengal tiger|Panthera tigris tigris (organism) | Panthera tigris tigris |
C0027708 | An embryonal neoplasm characterized by the presence of epithelial, mesenchymal, and blastema components. The vast majority of cases arise from the kidney. A small number of cases with morphologic features resembling Wilms tumor of the kidney have been reported arising from the ovary and the cervix. | Wilms Tumor of the Kidney|tumor wilm's|Embryonal adenosarcoma|tumor, Wilms'|Kidney Nephroblastoma|nephroblastoma|KIDNEY, CARCINOSARCOMA, EMBRYONAL|Wilm's tumor|Nephroblastoma (morphologic abnormality)|Wilms' Tumor|Wilms' Tumor of the Kidney|NEPHROBLASTOMA|Wilms' tumour|Wilms Tumor|KIDNEY, EMBRYONAL MIXED TUMOR|Renal Wilms Tumor|tumors wilm's|Wilms tumor (Nephroblastoma)|Nephroma, NOS|Embryonal Nephroma|tumor wilms'|Wilm's Tumor|Renal adenosarcoma|Wilms tumour|Tumor, Wilms'|wilms' tumour|Nephroblastomas|KIDNEY, ADENOMYOSARCOMA, EMBRYONAL|Wilm Tumor|Wilms Tumor 1|wilm's tumor|WILMS TUMOR 1|Nephroblastoma (disorder)|nephromas|tumors wilms|WILMS TUMOR|nephroma|Renal Wilms' Tumor|tumor wilms's|wilms tumor|Tumor, Wilms|Nephroblastoma (Wilms tumor)|tumor wilms|Wilms tumor|wilms' tumor|wilms tumour|Wilms tumor and other childhood kidney tumors|Kidney Wilms Tumor|Nephroblastoma|WT1|wilm tumor|Nephroma|Wilms' tumor and other childhood kidney tumors|Embryonal nephroma|Wilms' tumor|NEPHROBLASTOMA, MALIGNANT|RENAL CANCER, WILMS|KIDNEY, EMBRYOMA|Nephroblastoma, NOS | Nephroblastoma |
C0051727 | null | ammonium tungsten antimonate hydroxide oxide | ammonium tungsten antimonate hydroxide oxide |
C0051727 | null | ammonium tungsten antimonate hydroxide oxide | ammonium tungsten antimonate hydroxide oxide |
C0051727 | null | ammonium tungsten antimonate hydroxide oxide | ammonium tungsten antimonate hydroxide oxide |
C0051727 | null | ammonium tungsten antimonate hydroxide oxide | ammonium tungsten antimonate hydroxide oxide |
C0180063 | null | null | compressor |
C0524833 | A species of halophilic archaea found in salt lakes. Some strains form a PURPLE MEMBRANE under anaerobic conditions. | Halobacterium halobium|Halobacterium cutirubrum|Bacillus halobius ruber|Pseudomonas salinaria|Flavobacterium (subgen. Halobacterium) halobium|Halobacterium salinarium|Halobacter salinaria|Serratia salinaria|Halobacterium piscisalsi|Flavobacterium (subgen. Halobacterium) salinarium|Serratia cutirubrum|Bacterium halobium|Halobacterium salinarum|Halobacterium cutirubrum (organism)|Halobacterium salinarum (organism) | Halobacterium salinarium |
C0018440 | Integral membrane proteins that transport protons across a membrane. This transport can be linked to the hydrolysis of ADENOSINE TRIPHOSPHATE. What is referred to as proton pump inhibitors frequently is about POTASSIUM HYDROGEN ATPASE. | Pump, Proton|H+ Pump|Pumps, Proton|proton pumping|protons pump|Proton Pump|proton pumps|H(+) Pump|Pump, H+|proton pump|Proton Pumps | Proton Pump |
C0949664 | Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration. | tauopathies|Tauopathy|tauopathy | Tauopathies |
C0016733 | The part of the cerebral hemisphere anterior to the central sulcus, and anterior and superior to the lateral sulcus. | FRONTAL LOBE|Frontal Lobe|lobus frontalis|frontal lobe brain|Frontal Lobes|Frontal lobe, NOS|Frontali, Lobus|Lobus Frontalis|Frontal cortex|Frontal Cortex|Cortex, Frontal|FRONTAL LOBES|frontal cortex|Frontal lobe|frontal regions|Frontalis, Lobus|Regio frontalis|Lobes, Frontal|Frontal Cortices|Frontal lobe structure|Lobus frontalis|Cortices, Frontal|frontal lobe (brain)|Lobus Frontali|Lobe, Frontal|frontal lobe|Frontal region|brain frontal lobe|Frontal lobe structure (body structure)|Frontal lobes|frontal lobes|frontal brain lobe | frontal lobe |
C0023217 | The bones of the free part of the lower extremity in humans and of any of the four extremities in animals. It includes the PATELLA; TIBIA; and FIBULA. | of leg bones|Set of bones of lower limb|Bones of lower limb|bones of leg|Leg Bone|Bones of Leg|bones leg|leg bone|Bone, Leg|Lower limb skeleton|Skeleton of lower limb|bone legs|bone leg|leg bones|Ossa membri inferioris|Bones, Leg | Leg Bones |
C1281580 | null | Entire fibula|Entire fibula (body structure) | Entire fibula |
C0995158 | The species Orcinus orca, in the family Delphinidae, characterized by its black and white coloration, and huge triangular dorsal fin. It is the largest member of the DOLPHINS and derives its name from the fact that it is a fearsome predator. | Killer Whale|Whales, Killer|Whale, Killer|Killer whale|Orcinus orca (organism)|Killer Whales|Orca|Orcinus orca | Orcinus orca |
C0444414 | null | biocide|biocides|Biocide|Biocide (substance) | Biocides |
C0001272 | Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli. | Potential, Action|Action Potential|Potentials, Action|action potentials|action potential | Action Potentials |
C0034715 | A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. | Sprague-Dawley rat (organism)|Sprague-Dawley rat|Rats, Sprague Dawley|Sprague-Dawley Rats|Sprague Dawley Rats | Rats, Sprague-Dawley |
C1268983 | null | Entire third ventricle of brain|Entire third ventricle|Entire third ventricle (body structure) | Entire third ventricle |
C0021335 | A species of VARICELLOVIRUS that causes INFECTIOUS BOVINE RHINOTRACHEITIS and other associated syndromes in CATTLE. | Bovine herpesvirus 1|Bovine herpesvirus-1|Bovine herpesvirus type 1|Pustular Vulvovaginitis Virus, Infectious|Bovine rhinotracheitis virus|bovine herpesvirus type-1 BHV-1|Herpesvirus 1, Bovine|bovine herpesvirus BHV-1|Bovine Herpesvirus 1|IBR-IPV Viruses|IBR-IPV Virus|Infectious Bovine Rhinotracheitis Virus|infectious bovine rhinotracheitis virus BHV-1|bovine herpesvirus 1 BHV-1|Herpesvirus 1 (alpha), Bovine|Bovine Rhinotracheitis Virus, Infectious|bovine herpesvirus 1 BHV 1|IBR IPV Virus|infectious bovine rhinotracheitis virus|Viruses, IBR-IPV|bovine alphaherpesvirus 1|Infectious Pustular Vulvovaginitis Virus|bovine herpesvirus 1 BHV1|Virus, IBR-IPV|Infectious bovine rhinotracheitis virus|BHV-1|Bovid herpesvirus 1|bovine herpesvirus type 1 BHV-1|Bovine herpesvirus 1 (organism)|Bovine alphaherpesvirus 1 | Bovine herpesvirus 1 |
C0042212 | Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins. | inactivated vaccine|Inactivated Vaccine|Killed Vaccine|inactivated vaccines|Inactivated Vaccines|Killed Vaccines|Vaccines, Killed|killed vaccine | Vaccines, Inactivated |
C0227261 | Mucosa arranged into two fundamental structures - villi and crypts of Lieberkuhn. Villi are projections into the lumen of the small intestine, covered with simple columnar epithelium. Crypts of Lieberkuhn are moat-like invaginations of the epithelium around the villi that extend through the lamina propria down to the muscularis mucosae. Lymphocytes often invade the epithelium or form solitary lymphoid nodules in the lamina propria. Lymph nodules may form longitudinal aggregations of 30-50 nodules in the lamina propria of the ileum. These large aggregations are called Peyer's patches. The muscularis mucosae has two layers and extends into the intestinal villi, where the smooth muscle cells form a longitudinal bundle in the centre of the villi. The small intestinal mucosa secretes gastrin, somatostatin, cholecystokinin and secretin. | Small intestine mucous membrane structure (body structure)|Small intestinal mucosa|Small intestine mucous membrane structure|Small Intestinal Mucosa|Tunica mucosa intestini tenuis|Mucosa of small intestine|Mucous membrane of small intestine|Tunica mucosa (Intestinum tenue)|Small intestine mucous membrane | Small intestine mucous membrane |
C0002854 | The family of steroids from which the androgens are derived. | Androstane|Androstanes|Androstane (substance)|Product containing androstane (product)|androstanes|androstane|Androstane-containing product|androstane compound | Androstanes |
C1510835 | Any physiological aspect of aging; irreversible changes in an organism that occur over time and lead to a more mature condition. | Aging Process | Aging-Related Process |
C0010558 | A homologous group of cyclic GLUCANS consisting of alpha-1,4 bound glucose units obtained by the action of cyclodextrin glucanotransferase on starch or similar substrates. The enzyme is produced by certain species of Bacillus. Cyclodextrins form inclusion complexes with a wide variety of substances. | Cyclomaltooligosaccharides|Derivatives, Cyclodextrin|cyclodextrin|cyclodextrins|Cyclodextrin Derivatives|Cyclodextrins|Cycloamylose | cyclodextrins |
C0001044 | An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7. | Acetylcholinesterase (substance)|Acetylcholine Hydrolase|acetylcholine acetylhydrolase|Erythrocyte cholinesterase|Hydrolase, Acetylcholine|Choline esterase I|ACE - Acetylcholinesterase|AChE|acetylcholinesterase|RBC - Red blood cell cholinesterase|Acetylcholine esterase|choline esterase I|erythrocyte cholinesterase|ACHE - Acetylcholine esterase|acetylcholine hydrolase|Red blood cell cholinesterase|Acetylcholine acetylhydrolase|True cholinesterase|acetylcholinesterases|Acetylcholinesterase | acetylcholinesterase |
C0001044 | An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7. | Acetylcholinesterase (substance)|Acetylcholine Hydrolase|acetylcholine acetylhydrolase|Erythrocyte cholinesterase|Hydrolase, Acetylcholine|Choline esterase I|ACE - Acetylcholinesterase|AChE|acetylcholinesterase|RBC - Red blood cell cholinesterase|Acetylcholine esterase|choline esterase I|erythrocyte cholinesterase|ACHE - Acetylcholine esterase|acetylcholine hydrolase|Red blood cell cholinesterase|Acetylcholine acetylhydrolase|True cholinesterase|acetylcholinesterases|Acetylcholinesterase | acetylcholinesterase |
C0998140 | null | Scapharca inaequivalvis | Scapharca inaequivalvis |
C0066474 | null | null | metribuzin |
C0331716 | A form-genus of CYANOBACTERIA in the order Chroococcales. Many species are planktonic and possess gas vacuoles. | Microcystis|microcystis|Genus Microcystis (organism)|Genus Microcystis|Microcystis, NOS | Microcystis |
C0524480 | A genus of GREEN ALGAE in the family Scenedesmaceae. It forms colonies of usually four or eight cylindrical cells that are widely distributed in freshwater and SOIL. | Scenedesmus|Schroederiella | Scenedesmus |
C0331718 | null | Microcystis aeruginosa|Microcystis aeruginosa (organism) | Microcystis aeruginosa |
C0996446 | null | Acutodesmus obliquus|Achnanthes obliqua|Scenedesmus obliquus | Tetradesmus obliquus |
C0031354 | A funnel-shaped fibromuscular tube that conducts food to the ESOPHAGUS, and air to the LARYNX and LUNGS. It is located posterior to the NASAL CAVITY; ORAL CAVITY; and LARYNX, and extends from the SKULL BASE to the inferior border of the CRICOID CARTILAGE anteriorly and to the inferior border of the C6 vertebra posteriorly. It is divided into the NASOPHARYNX; OROPHARYNX; and HYPOPHARYNX (laryngopharynx). | throat|throats|Throats|Pharyngeal|Pharynx|pharyngeal|PHARYNX|Pharyngeal structure|pharynx|Pharynx, NOS|Pharyngo-|Pharyngeal structure (body structure)|Pharynxs|Throat | Pharyngeal structure |
C0723796 | null | trace metals|trace metal | Trace metal |
C0003805 | An enzyme that catalyzes the desaturation (aromatization) of the ring A of C19 androgens and converts them to C18 estrogens. In this process, the 19-methyl is removed. This enzyme is membrane-bound, located in the endoplasmic reticulum of estrogen-producing cells of ovaries, placenta, testes, adipose, and brain tissues. Aromatase is encoded by the CYP19 gene, and functions in complex with NADPH-FERRIHEMOPROTEIN REDUCTASE in the cytochrome P-450 system. | Protein, CYP19|CYP 19|EC 1.14.14.1|estrogen synthase|AROM|CYP19 Protein|CYP19|Androstenedione Aromatase|aromatases|Cytochrome P 450 CYP19|Cytochrome P-450(AROM)|P450AROM|Cytochrome P450 19|Aromatase, Androstenedione|aromatase|Estrogen Synthase|Estrogen Synthetase|Cytochrome P-450 CYP19|Aromatase | Aromatase |
C0046725 | null | 17beta-Hydroxysteroid dehydrogenase|3beta-hydroxysteroid dehydrogenase (substance)|3 (or 17)-beta-hydroxysteroid dehydrogenase|17 beta-hydroxysteroid dehydrogenase|17beta-hydroxysteroid dehydrogenase|3beta-hydroxysteroid dehydrogenase|3,17-beta-HSDase|3 beta,17 beta-hydroxysteroid dehydrogenase|3beta-Hydroxysteroid dehydrogenase | 3 (or 17)-beta-hydroxysteroid dehydrogenase |
C0972401 | null | boards|board|board [device] | Boards (medical device) |
C0948364 | null | Peri-prosthetic osteolysis|Osteolysis of bone adjacent to prosthesis (disorder)|Osteolysis of bone adjacent to prosthesis | Periprosthetic osteolysis |
C0950151 | The period of cyclic physiological and behavior changes in non-primate female mammals that exhibit ESTRUS. The estrous cycle generally consists of 4 or 5 distinct periods corresponding to the endocrine status (PROESTRUS; ESTRUS; METESTRUS; DIESTRUS; and ANESTRUS). | estrous cycle|cycle estrous|Estrous Cycles|Cycles, Estrous|Cycle, Estrous|Estrous Cycle | Estrous Cycle |
C0205753 | The endogenous peptides with opiate-like activity. The three major classes currently recognized are the ENKEPHALINS, the DYNORPHINS, and the ENDORPHINS. Each of these families derives from different precursors, proenkephalin, prodynorphin, and PRO-OPIOMELANOCORTIN, respectively. There are also at least three classes of OPIOID RECEPTORS, but the peptide families do not map to the receptors in a simple way. | Peptide, Opioid|Peptides, Opiate|opioid peptide|opiate peptide|Opioid peptides|Peptides, Opioid|Opiate Peptides|Opioid Peptides|Opioid Peptide|endogenous opioid peptides|opioid peptides | Opioid Peptide |
C0014948 | The period in the ESTROUS CYCLE associated with maximum sexual receptivity and fertility in non-primate female mammals. | Estrus, function|Estrus (finding)|oestrus|Estrus, function (observable entity)|Oestrus|Estrus, estrus|Estrus|Oestrus, NOS|estrus|Estrus, NOS|estrous | Estrus |
C0033274 | A phase of the ESTROUS CYCLE that precedes ESTRUS. During proestrus, the Graafian follicles undergo maturation. | proestrus|Pro-oestrus|Proestrus (finding)|Proestrus | Proestrus |
C0398523 | A procedure in which a small sample of bone marrow is removed, usually from the hip bone, breastbone, or thigh bone. A small area of skin and the surface of the bone underneath are numbed with an anesthetic. Then, a special wide needle is pushed into the bone. A sample of liquid bone marrow is removed with a syringe attached to the needle. The bone marrow is sent to a laboratory to be looked at under a microscope. This procedure may be done at the same time as a bone marrow biopsy. | bone marrow aspiration procedure|aspiration bone marrow|Bone Marrow Aspiration|aspirations bone marrow|bone marrow aspiration|Bone marrow tap|bone marrow tap|Bone marrow aspiration procedure|Bone marrow aspiration procedure, NOS|Bone marrow aspiration procedure (procedure)|Bone marrow aspiration | Bone marrow aspiration procedure |
C0057256 | Family of antimicrobial peptides that have been identified in humans, animals, and plants. They are thought to play a role in host defenses against infections, inflammation, wound repair, and acquired immunity. | Defensins|defensins|defensin | Defensins |
C0057256 | Family of antimicrobial peptides that have been identified in humans, animals, and plants. They are thought to play a role in host defenses against infections, inflammation, wound repair, and acquired immunity. | Defensins|defensins|defensin | Defensins |
C0074989 | null | Sphingomyelin phosphodiesterase D (substance)|sphingomyelin ceramide-phosphodiesterase|Sphingomyelin phosphodiesterase D|sphingomyelin phosphodiesterase D|sphingomyelinase D | sphingomyelin phosphodiesterase D |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.